
5 Flucel 250Mg Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/mL (2.5 g/50 mL and 5 g/100 mL vials)
Reference Brands: Adrucil(US),Fluorouracil Accord & Fluorouracil Sandoz(EU)
Category: Oncology Cancer Care
5 Flucel 250mg Injection is available in Injection and strengths such as 50 mg/mL (2.5 g/50 mL and 5 g/100 mL vials). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, 5 Flucel 250mg Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
5 Flucel 250mg Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: 5 Flucel 250mg Injection contains fluorouracil, an antimetabolite used in oncology for treating various cancers such as colorectal, breast, and stomach cancer. Available in India and select international markets, 5 Flucel is administered intravenously and comes in a 250mg/5ml formulation. In the US, fluorouracil is marketed under the brand Adrucil® and available in 50 mg/mL concentrations. In the EU, it is sold under brands like Fluorouracil Injection by medac and Sandoz. With a focus on oncology, it offers a trusted solution for cancer treatment. Ideal for B2B pharmaceutical companies seeking to expand oncology portfolios globally.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers